Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
Abena Minta(The Ohio State University), Brittany Dulmage(The Ohio State University), Margaret E. Gatti‐Mays(National Cancer Institute), Elizabeth Cathcart-Rake(Mayo Clinic), Kathryn J. Ruddy(Mayo Clinic in Arizona), Robert Wesolowski(The Ohio State University Wexner Medical Center), Lucy Rose(The Ohio State University), Nicole Williams(The Ohio State University), Daniel G. Stover(Harvard University), Candice Park(The Ohio State University Wexner Medical Center), Sagar Sardesai(The Ohio State University Wexner Medical Center), Bhuvaneswari Ramaswamy(The Ohio State University), Mathew Cherian(The Ohio State University Wexner Medical Center), Maryam B. Lustberg(Yale Cancer Center), Charles L. Loprinzi(Mayo Clinic in Arizona), Stephanie Trovato(The Ohio State University Wexner Medical Center), Preeti Sudheendra(Cooper University Health Care)
Cited by 11
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991